Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) PPARGC1B Antibodies:
anti-Rat (Rattus) PPARGC1B Antibodies:
anti-Human PPARGC1B Antibodies:
Go to our pre-filtered search.
We conclude that while activation of muscle PGC-1beta is sufficient to drive the complete endurance phenotype in sedentary mice, it only partially prevents the detraining response following exercise training, suggesting that the process of endurance detraining involves mechanisms beyond the reversal of muscle autonomous mechanisms involved in endurance fitness.
Data suggest that PGC-1alpha (show PPARGC1A Antibodies) and -1beta expression are not required for training-induced exercise performance, highlighting the contribution of PGC-1 (show PPARGC1A Antibodies)-independent mechanisms.
We confirmed that PGC (show PGC Antibodies)-1b inhibited downstream inflammatory signals via binding with TAB1 (show TAB1 Antibodies) and thus preventing TAB1 (show TAB1 Antibodies)/TAK1 (show NR2C2 Antibodies) binding and TAK1 (show NR2C2 Antibodies) activation.
the anti-inflammatory environment in muscle promoted by the PGC (show PGC Antibodies)-1s might contribute to the beneficial effects of these coactivators on muscle function and provides a molecular link underlying the tight mutual regulation of metabolism and inflammation
PGC1beta represses proangiogenic genes and stimulates antiangiogenic genes in muscle ischemia. PGC1beta inhibits neoangiogenesis and blocks ischemic revascularization.
The data indicate a novel detrimental age-dependent role of PPAR beta (show PPARD Antibodies)/delta in Alzheimer disease by increasing pro-BDNF (show BDNF Antibodies) and decreasing BDNF (show BDNF Antibodies)/TrkB (show NTRK2 Antibodies) survival pathways.
The results highlight a novel function for SYVN1 (show SYVN1 Antibodies) in the control of body weight and mitochondrial biogenesis through negative regulation of PGC (show PGC Antibodies)-1b.
PGC-1beta in the gut (show GUSB Antibodies) acts as an adaptive self-point regulator, capable of providing a balance between enhanced mitochondrial activity and protection from increased ROS (show ROS1 Antibodies) production
Fisetin regulates the expression of hepatic lipid metabolism genes by downregulating miR (show MLXIP Antibodies)-378 and the host gene PGC-1beta.
Our aim was to assess the role of PGC-1 (show PPARGC1A Antibodies) coactivators during postnatal cardiac development and in adult hearts in mice.
The presence of the PPARGC1B (Ala203Pro) SNP did not modify the association between inorganic arsenic methylation capacity and breast cancer.
Genetic variants of PPARGC1B are significantly associated with gout, and a missense single nucleotide polymorphism, rs45520937, augments NLRP3 (show NLRP3 Antibodies) and IL-1beta (show IL1B Antibodies) expression
the forkhead box O3 (FOXO3 (show FOXO3 Antibodies))/liver kinase B1 (LKB1 (show STK11 Antibodies))/AMP-activated protein kinase (show PRKAA2 Antibodies)/peroxisome proliferator-activated receptor-gamma (show PPARG Antibodies) co-activator-1beta (PGC-1beta)/pyruvate dehydrogenase (show PDP Antibodies)-A1 pathway is essential for CD44 (show CD44 Antibodies) expression and cancer stem cells properties.
We also suggest a novel hepatic protective role of PGC1B as a modulator of E2 effects on mitochondrial biogenesis
we show an association of HER2 (show ERBB2 Antibodies)-overexpression and PGC-1beta. PGC-1beta knockdown impairs HER2 (show ERBB2 Antibodies)-overexpressing cells proliferation acting on ERRalpha (show ESRRA Antibodies) signaling, metabolism, and redox balance.
Further replication study confirmed the association signals of rs4705372 (P = 0.0026) and rs11743128 (P = 0.0387) in the independent validation sample. Our study results suggest that PPARGC1B is a novel susceptibility gene of Kashin-Beck disease .
Human influenza hemagglutinin (show HA Antibodies)-tagged PPARGC1B coprecipitated more intensely with ERalpha (show ESR1 Antibodies) in the +102525A than the +102525G construct after 17beta estradiol treatment
Data suggest that PGC-1alpha (show PPARGC1A Antibodies) and PGC-1beta could play a role in regulating retina cell survival, and may be therapeutic targets to prevent retinal degeneration.
PGC-1(beta) and estrogen-related receptor alpha (show ESRRA Antibodies) are aberrantly expressed in human colon cell lines and tumors.
RUNX3 (show RUNX3 Antibodies) is related to both the severity of AS and the function of daily life. PPARGC1B is related to the function of daily life.
The protein encoded by this gene stimulates the activity of several transcription factors and nuclear receptors, including estrogen receptor alpha, nuclear respiratory factor 1, and glucocorticoid receptor. The encoded protein may be involved in fat oxidation, non-oxidative glucose metabolism, and the regulation of energy expenditure. This protein is downregulated in prediabetic and type 2 diabetes mellitus patients. Certain allelic variations in this gene increase the risk of the development of obesity. Three transcript variants encoding different isoforms have been found for this gene.
peroxisome proliferator-activated receptor gamma, coactivator 1 beta
, peroxisome proliferator-activated receptor gamma coactivator 1-beta-like
, ERR ligand 1
, PPAR gamma coactivator-1beta protein
, PPAR-gamma coactivator 1-beta
, peroxisome proliferator-activated receptor gamma coactivator 1 beta
, peroxisome proliferator-activated receptor gamma coactivator 1-beta
, peroxisome proliferative activated receptor, gamma, coactivator 1 beta
, peroxisome proliferator-activated receptor gamma coactivator 1beta-2a
, PGC-1-related estrogen receptor alpha coactivator